title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study",20220802T122759,https://www.benzinga.com/general/biotech/22/08/28308082/biotech-daily-trial-setback-for-eliem-therapeutics-allarity-drops-work-on-cancer-monotherapies-ax,KRYS,0.105372,Neutral,0.112291
"Gene Therapy Market Set for 19% CAGR Surge, Reaching USD 38.34 Billion by 2031 | SkyQuest Technology",20240912T133000,https://www.benzinga.com/pressreleases/24/09/g40833623/gene-therapy-market-set-for-19-cagr-surge-reaching-usd-38-34-billion-by-2031-skyquest-technology,KRYS,0.039878,Neutral,0.026899
"NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday - Dave  ( NASDAQ:DAVE ) , NIO  ( NYSE:NIO ) , Riskified  ( NYSE:RSKD ) ",20240305T155657,https://www.benzinga.com/news/24/03/37486513/nio-reports-upbeat-earnings-joins-dave-v2x-riskified-and-other-big-stocks-moving-higher-on-tuesday,KRYS,0.153961,Bullish,0.43667
